Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Apr 21, 2026
Reporting period
Not applicable
Filed with the SEC
Apr 23, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001343989-26-000002
Filed / recorded
Apr 23, 2026, 7:23 PM UTC
Added to OQRO
Oct 6, 2026, 4:40 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
BIO-RAD LABORATORIES, INC.
Issuer CIK
12208
Ticker
BIO BIO.B
Reporting person
Arnold A Pinkston
Relationship
Director
Security
Restricted Stock Units
Table
Derivative (Table II)
Transaction date
Apr 21, 2026
Transaction code
A
Shares / units
369
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
369
Ownership form
Direct
Amendment
No
Footnotes from the filing
Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders.